Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Behin

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Annals of Clinical and Translational Neurology|April 25, 2015
Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patientsGaëlle Bruneteau, Stéphanie Bauché, Jose Luis Gonzalez de Aguilar, et al.
Neuroimage. Clinical|December 8, 2018
The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging studyGiorgia Querin, Mohamed-Mounir El Mendili, Timothée Lenglet, et al.
Neurology|July 7, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022Claire Lefeuvre, Marie De Antonio, Francoise Bouhour, et al.
Neurology. Genetics|July 20, 2023
Phenotype Presentation and Molecular Diagnostic Yield in Non-5q Spinal Muscular AtrophyGorka Fernández-Eulate, Julian Theuriet, Christopher J Record, et al.
Brain : a Journal of Neurology|April 27, 2017
A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathiesMarie Coutelier, Giulia Coarelli, Marie-Lorraine Monin, et al.
European Journal of Neurology|March 14, 2021
Deep phenotyping of an international series of patients with late-onset dysferlinopathyGorka Fernández-Eulate, Giorgia Querin, Ursula Moore, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Neurology|April 14, 2019
FSHD1 and FSHD2 form a disease continuumSabrina Sacconi, Audrey Briand-Suleau, Marilyn Gros, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Orphanet Journal of Rare Diseases|January 24, 2024
Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatmentsEmmanuelle Salort-Campana, Guilhem Solé, Armelle Magot, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Annals of Clinical and Translational Neurology|April 25, 2015
Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patientsGaëlle Bruneteau, Stéphanie Bauché, Jose Luis Gonzalez de Aguilar, et al.
Neuroimage. Clinical|December 8, 2018
The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging studyGiorgia Querin, Mohamed-Mounir El Mendili, Timothée Lenglet, et al.
Neurology|July 7, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022Claire Lefeuvre, Marie De Antonio, Francoise Bouhour, et al.
Neurology. Genetics|July 20, 2023
Phenotype Presentation and Molecular Diagnostic Yield in Non-5q Spinal Muscular AtrophyGorka Fernández-Eulate, Julian Theuriet, Christopher J Record, et al.
Brain : a Journal of Neurology|April 27, 2017
A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathiesMarie Coutelier, Giulia Coarelli, Marie-Lorraine Monin, et al.
European Journal of Neurology|March 14, 2021
Deep phenotyping of an international series of patients with late-onset dysferlinopathyGorka Fernández-Eulate, Giorgia Querin, Ursula Moore, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Neurology|April 14, 2019
FSHD1 and FSHD2 form a disease continuumSabrina Sacconi, Audrey Briand-Suleau, Marilyn Gros, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Orphanet Journal of Rare Diseases|January 24, 2024
Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatmentsEmmanuelle Salort-Campana, Guilhem Solé, Armelle Magot, et al.
Pageof 10